Search - Archive ouverte HAL Access content directly

Filter your results

16 Results
authFullName_s : N. Vey

Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study.

N. Vey , X. Thomas , C. Picard , T. Kovascovicz , C. Charin et al.
Leukemia, 2006, 20 (12), pp.2155-61. ⟨10.1038/sj.leu.2404420⟩
Journal articles hal-00453293v1
Image document

Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs

C Faucher , A Le Corroller Soriano , B Esterni , N. Vey , A Stoppa et al.
Bone Marrow Transplantation, 2012, 47 (4), pp.549-555. ⟨10.1038/bmt.2011.126⟩
Journal articles inserm-02294378v1

Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights

J.E. Martin , S. Khalife-Hachem , T. Grinda , M. Kfoury , S. Garciaz et al.
Annals of Oncology, 2021, 32 (8), pp.1046-1048. ⟨10.1016/j.annonc.2021.04.015⟩
Journal articles hal-03623367v1
Image document

A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study

A. Collignon , M. A Hospital , C. Montersino , F. Courtier , A. Charbonnier et al.
Blood Cancer Journal, 2020, 10 (6), pp.64. ⟨10.1038/s41408-020-0330-5⟩
Journal articles inserm-03038330v1

Human V 9V 2 T Cells Specifically Recognize and Kill Acute Myeloid Leukemic Blasts

J. Gertner-Dardenne , R. Castellano , Emilie Mamessier , S. Garbit , E. Kochbati et al.
Journal of Immunology, 2012, 188 (9), pp.4701 - 4708. ⟨10.4049/jimmunol.1103710⟩
Journal articles hal-01765650v1

A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse.

S. Park , N. Chapuis , Franck Saint-Marcoux , C. Recher , T. Prebet et al.
Leukemia, 2013, 27 (7), pp.1479-86. ⟨10.1038/leu.2013.17⟩
Journal articles hal-00849677v1

BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia.

Audrey Benyamine , A. Le Roy , Emilie Mamessier , J. Gertner-Dardenne , C. Castanier et al.
Journal articles inserm-01416288v1

Long-term results of a randomized phase 3 trial comparing idarubicin and daunorubicin in younger patients with acute myeloid leukaemia.

C. Récher , M. C. Béné , B. Lioure , A. Pigneux , N. Vey et al.
Leukemia, 2014, 28 (2), pp.440-3. ⟨10.1038/leu.2013.290⟩
Journal articles hal-00979453v1

Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts

V. Gelsi-Boyer , N. Cervera , François Bertucci , M. Brecqueville , P. Finetti et al.
Haematologica, 2013, 98 (4), pp.576-583. ⟨10.3324/haematol.2012.071506⟩
Journal articles hal-03623773v1

Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia

S. Maury , S. Chevret , X. Thomas , D. Heim , T. Leguay et al.
New England Journal of Medicine, 2016, 375, pp.1044--1053. ⟨10.1056/NEJMoa1605085⟩
Journal articles hal-01812704v1

Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents

M Duchmann , B Braun , J.B. Micol , P Platzbecker , P. Park et al.
Blood Cancer Journal, 2017, 7 (5), pp.e562. ⟨10.1038/bcj.2017.41⟩
Journal articles hal-01655936v1
Image document

Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights

J.E. Martin , S. Khalife-Hachem , T. Grinda , M. Kfoury , S. Garciaz et al.
Annals of Oncology, 2021, 32 (8), pp.1046-1048. ⟨10.1016/j.annonc.2021.04.015⟩
Journal articles hal-03376715v1

Array comparative genomic hybridization and sequencing of 23 genes in 80 patients with myelofibrosis at chronic or acute phase

M. Brecqueville , J. Rey , R. Devillier , A. Guille , R. Gillet et al.
Haematologica, 2014, 99 (1), pp.37-45. ⟨10.3324/haematol.2013.091454⟩
Journal articles hal-03634242v1

A conditioning platform based on fludarabine, busulfan and two days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor.

R. Devillier , S. Fürst , R. Crocchiolo , J. El-Cheikh , L. Castagna et al.
American Journal of Hematology, 2014, 89 (1), pp.83-7. ⟨10.1002/ajh.23592⟩
Journal articles hal-00903457v1

Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia

M. Bonnet , M. Loosveld , B. Montpellier , Navarro J.M. , B. Quillichini et al.
Blood, 2011, 117, pp.6650-6659
Journal articles hal-00616996v1

Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study

C. Berthon , E. Raffoux , X. Thomas , N. Vey , C. Gomez-Roca et al.
Lancet Haematology, 2016, 3 (4), pp.e186-e195. ⟨10.1016/S2352-3026(15)00247-1⟩
Journal articles hal-01791279v1